{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:43:01Z","timestamp":1783633381812,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The pathogenesis of tumor-induced osteolysis (TIO) following breast cancer metastases in bone remains unclear. We postulated that osteoblasts could be target cells for the secretory products of breast cancer cells. We previously showed that serum-free conditioned medium (CM) of the breast cancer cell line MCF-7 inhibits DNA synthesis by 75% of control values in osteoblast-like cells SaOS-2 and that this effect is only in a minor part due to transforming growth factor \u03b2 secretion. To establish the specificity of our observations and to look for other biologically active factors, we have tested the effects of medium conditioned by several cancer and noncancer cell lines (breast, colon, placenta, or fibrosarcoma) on the proliferation of osteoblast-like cells (SaOS-2, MG-63), normal human osteoblasts, human fibrosarcoma cells, and normal human fibroblasts. Culture medium (1:2) of the breast cancer cell lines MCF-7, T-47D, MDA-MB-231, and SK-BR-3 inhibited by 25\u201350% the proliferation of osteoblast-like cells SaOS-2, MG-63, and normal osteoblasts as evaluated by the MTT survival test or [3H]thymidine incorporation. MCF-7 cells completely inhibited the proliferation of normal human osteoblasts in coculture. This inhibitory effect was reversible and not due to cytotoxicity. Moreover, the cyclic adenosine monophosphate (cAMP) response to parathyroid hormone (PTH) of osteoblast-like cells SaOS-2 was also increased by 100\u2013240% by the same CM. Such activities were, however, not detected in medium from the breast noncancer cell line HBL-100 or in the medium conditioned by non\u2013breast cancer cell lines (COLO 320DM, HT-29, JAR, or HT-1080). Medium from the breast cancer cells had no effect on normal human fibroblasts or fibrosarcoma cells (HT-1080), suggesting the specificity of their action on human osteoblasts. After partial purification by ultrafiltration and size-exclusion chromatography, we found that medium of T-47D cells contained at least three nonprostanoid factors of low molecular weights (apparent MW of 700, 1500, and 4000 D) which affected human osteoblast-like cells. These factors were heat stable and could be peptides without disulfide bonds. In summary, our data show that human breast cancer cells release soluble factors that inhibit osteoblast proliferation and increase their cAMP response to PTH, indicating that osteoblasts could be important target cells for breast cancer cells and could be involved in the process of TIO.<\/jats:p>","DOI":"10.1359\/jbmr.1997.12.4.552","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T22:14:04Z","timestamp":1146089644000},"page":"552-560","source":"Crossref","is-referenced-by-count":25,"title":["Secretory Products of Breast Cancer Cells Specifically Affect Human Osteoblastic Cells: Partial Characterization of Active Factors"],"prefix":"10.1093","volume":"12","author":[{"given":"Brigitte","family":"Siwek","sequence":"first","affiliation":[{"name":"Bone Metabolism Unit, Service de M\u00e9decine et Laboratoire d'Investigation Clinique H.J. Tagnon, Institut J. Bordet, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lacroix","sequence":"additional","affiliation":[{"name":"Bone Metabolism Unit, Service de M\u00e9decine et Laboratoire d'Investigation Clinique H.J. Tagnon, Institut J. Bordet, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"De Pollak","sequence":"additional","affiliation":[{"name":"Cell and Molecular Biology of Bone and Cartilage, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marie","sequence":"additional","affiliation":[{"name":"Cell and Molecular Biology of Bone and Cartilage, H\u00f4pital Lariboisi\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[{"name":"Bone Metabolism Unit, Service de M\u00e9decine et Laboratoire d'Investigation Clinique H.J. Tagnon, Institut J. Bordet, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"2024020720024246100_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(09)80011-2","article-title":"Metastatic bone disease: Clinical and therapeutic aspects","volume":"13","author":"Body","year":"1992","journal-title":"Bone"},{"key":"2024020720024246100_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"2024020720024246100_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/276726a0","article-title":"Direct resorption of bone by human breast cancer cells in vitro","volume":"276","author":"Eilon","year":"1978","journal-title":"Nature"},{"key":"2024020720024246100_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","article-title":"Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer","volume":"15","author":"Taube","year":"1994","journal-title":"Bone"},{"key":"2024020720024246100_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/8756-3282(91)90057-P","article-title":"Mechanisms of osteolytic bone destruction","volume":"12","author":"Mundy","year":"1991","journal-title":"Bone"},{"key":"2024020720024246100_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1992.108","article-title":"Human tumour-associated macrophages are capable of bone resorption","volume":"65","author":"Athanasou","year":"1992","journal-title":"Br J Cancer"},{"key":"2024020720024246100_bib7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/endo-119-4-1654","article-title":"Osteoblast-like cells in the presence of parathyroid hormone release a soluble factor that stimulates osteoclastic bone resorption","volume":"119","author":"McSheehy","year":"1986","journal-title":"Endocrinology"},{"key":"2024020720024246100_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1172\/JCI113089","article-title":"1,25-dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption","volume":"80","author":"McSheehy","year":"1987","journal-title":"J Clin Invest"},{"key":"2024020720024246100_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0006-291X(89)92651-X","article-title":"Transforming growth factor-beta-induced mitogenesis of human bone cancer cells","volume":"161","author":"Datta","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2024020720024246100_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jbmr.5650070510","article-title":"Effect of transforming growth factor beta on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cells","volume":"7","author":"Seitz","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020720024246100_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01806675","article-title":"Effects of secretory products of breast cancer cells on osteoblast-like cells","volume":"38","author":"Lacroix","year":"1996","journal-title":"Br Cancer Res Treat"},{"key":"2024020720024246100_bib12","first-page":"328","article-title":"HBL-100, a new cell line established from human breast milk","volume":"12","author":"Polanowski","year":"1976","journal-title":"In Vitro"},{"key":"2024020720024246100_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF02624601","article-title":"Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces","volume":"25","author":"Marie","year":"1989","journal-title":"In Vitro Cell Dev Biol"},{"key":"2024020720024246100_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Meth"},{"key":"2024020720024246100_bib15","first-page":"974","article-title":"Urinary cyclic 3\u2032,5\u2032-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism","volume":"96","author":"Heath","year":"1980","journal-title":"J Lab Clin Med"},{"key":"2024020720024246100_bib16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1986.4.8.1177","article-title":"Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate","volume":"4","author":"Body","year":"1986","journal-title":"J Clin Oncol"},{"key":"2024020720024246100_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a058175","article-title":"Malignant bone resorption: Cellular and biochemical mechanisms","volume":"3","author":"Dodwell","year":"1992","journal-title":"Ann Oncol"},{"key":"2024020720024246100_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-55-2-219","article-title":"Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: Uncoupling of bone cell activity","volume":"55","author":"Stewart","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020720024246100_bib19","first-page":"40","article-title":"The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-\u03b1 enhance hypercalcemia in vivo and bone resorption in vitro","volume":"77","author":"Guise","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020720024246100_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00060793-199512000-00013","article-title":"Breast cancer and bone","volume":"2","author":"Guise","year":"1995","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"2024020720024246100_bib21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jbmr.5650051110","article-title":"Bone cell responsiveness to transforming growth factor b, parathyroid hormone and prostaglandin E2 in normal and posmenopausal osteoporotic women","volume":"5","author":"Lomri","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024020720024246100_bib22","first-page":"3059","article-title":"Localization of parathyroid hormone-related protein in breast cancer metastasis: Increased incidence in bone compared with other sites","volume":"51","author":"Powell","year":"1991","journal-title":"Cancer Res"},{"key":"2024020720024246100_bib23","first-page":"5076","article-title":"Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases","volume":"53","author":"Bouizar","year":"1993","journal-title":"Cancer Res"},{"key":"2024020720024246100_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/jbmr.5650060905","article-title":"Adenylate cyclase stimulating activity immunologically similar to parathyroid hormone\u2013related peptide can be extracted from fetal rat long bones","volume":"6","author":"Nijs-De","year":"1991","journal-title":"J Bone Miner Res"},{"key":"2024020720024246100_bib25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jbmr.5650070715","article-title":"Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increases osteoclastic bone resorption","volume":"7","author":"Yates","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2024020720024246100_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00666476","article-title":"Pronostic relevance of transforming growth factor alpha (TGF-\u03b1) and tumor necrosis factor alpha (TNF-\u03b1) detected in breast cancer tissues by immunohistochemistry","volume":"29","author":"Bebok","year":"1994","journal-title":"Br Cancer Res Treat"},{"key":"2024020720024246100_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.138.3.775","article-title":"Tumor necrosis factor alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption","volume":"138","author":"Thomson","year":"1987","journal-title":"J Immunol"},{"key":"2024020720024246100_bib28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jor.1100140309","article-title":"Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis","volume":"14","author":"Clohisy","year":"1996","journal-title":"J Orthop Res"},{"key":"2024020720024246100_bib29","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1997.12.4.552","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/12\/4\/552\/56615399\/5650120407_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/12\/4\/552\/56615399\/5650120407_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:54:53Z","timestamp":1710341693000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/12\/4\/552-560\/7514262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4,1]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,4]]},"published-print":{"date-parts":[[1997,4,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1997.12.4.552","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,4,1]]},"published":{"date-parts":[[1997,4,1]]}}}